Latest Articles
Advocates demand apology after Marty Sheargold says endometriosis is 'made up' - PinkNews
Advocates demand apology after Marty Sheargold says endometriosis is 'made up' PinkNews
Published: Feb. 28, 2025, 5:56 a.m.
Advocates demand apology after Marty Sheargold’s ‘disgusting’ comments on endometriosis resurface - PinkNews
Advocates demand apology after Marty Sheargold’s ‘disgusting’ comments on endometriosis resurface PinkNews
Published: Feb. 28, 2025, 5:56 a.m.
Vagina Museum creates vagina-shaped empanada to raise funds, awareness - blooloop
Vagina Museum creates vagina-shaped empanada to raise funds, awareness blooloop
Published: Feb. 27, 2025, 12:30 p.m.
Canadian Biotech Afynia Raises $5M to Commercialize Blood Test for Endometriosis - Femtech Insider
Canadian Biotech Afynia Raises $5M to Commercialize Blood Test for Endometriosis Femtech Insider
Published: Feb. 27, 2025, 7:52 a.m.
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (PFE) - TradingView
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (PFE) TradingView
Published: Feb. 27, 2025, 7:36 a.m.
The long noncoding RNA LUCAT1 regulates endometrial receptivity via the miR-495-3p/S100P axis - Nature.com
The long noncoding RNA LUCAT1 regulates endometrial receptivity via the miR-495-3p/S100P axis Nature.com
Published: Feb. 26, 2025, 5:12 p.m.
Matildas, Made Up Endometriosis and Misogyny: Marty Sheargold's latest 'jokes' backfire - substack.com
Matildas, Made Up Endometriosis and Misogyny: Marty Sheargold's latest 'jokes' backfire substack.com
Published: Feb. 26, 2025, 6:18 a.m.
University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis - TechCrunch
University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis TechCrunch
Published: Feb. 25, 2025, 5:10 p.m.
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - Markets Insider
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. Markets Insider
Published: Feb. 25, 2025, 1:10 p.m.
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - The Manila Times
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. The Manila Times
Published: Feb. 25, 2025, 10:48 a.m.
Link copied to clipboard!